{"id":"NCT00647270","sponsor":"Abbott","briefTitle":"Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing","officialTitle":"A Multi-center, Randomized, Double-blind,Placebo-controlled Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2009-04","completion":"2009-04","firstPosted":"2008-03-31","resultsPosted":"2010-05-10","lastUpdate":"2011-04-11"},"enrollment":420,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"adalimumab","otherNames":["ABT-D2E7","Humira"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"adalimumab","otherNames":["ABT-D2E7","Humira"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"40 mg","type":"ACTIVE_COMPARATOR"},{"label":"80 mg","type":"ACTIVE_COMPARATOR"}],"summary":"To demonstrate the efficacy of 80 mg adalimumab monthly dosing compared with placebo and demonstrate the non-inferiority of monthly dosing of 80 mg adalimumab compared with dosing of 40 mg adalimumab every other week.","primaryOutcome":{"measure":"The Number of Responders According to the American College of Rheumatology (ACR) 20 Response Criteria at Week 12 Involving the Comparison of Adalimumab 80 mg Monthly Dose Versus Placebo and Adalimumab 40 mg Every Other Week (Eow)","timeFrame":"Week 12","effectByArm":[{"arm":"Placebo","deltaMin":19,"sd":null},{"arm":"Adalimumab 40 mg Eow","deltaMin":80,"sd":null},{"arm":"Adalimumab 80 mg Monthly","deltaMin":97,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.074"},{"comp":"OG001 vs OG002","p":"0.74"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":86,"countries":["United States","Australia","Canada","Germany","Puerto Rico","United Kingdom"]},"refs":{"pmids":["27338778"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":57},"commonTop":["upper respiratory tract infection","nasopharyngitis","nausea","headache","dizziness"]}}